Cancer / Oncology
Hanmi Pharmaceutical Partners with MSD to Advance Immuno-Oncology Drug BH3120 in New Clinical Trial
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesit...
April 24, 2024 | News
OSR Holdings and SillaJen Forge Strategic Partnership to Enhance Immuno-Oncology Drug Development
OSR Holdings, a global healthcare holding company, announced that it has signed a memorandum of understanding (MOU) with SillaJen, a Kosdaq-listed biotech ...
April 23, 2024 | News
COTA and Sanofi Forge Partnership to Enhance Oncology Trials with AI and Real-World Data
COTA, a leader in real-world data (RWD) and analytics for oncology, today announced a strategic collaboration with Sanofi to use RWD and artificial intelli...
April 18, 2024 | News
Serum Institute of India and Univercells Unite to Make Personalized Cancer Treatments Widely Available
Serum Institute of India (SII), the world’s largest vaccine manufacturer, has joined forces with Univercells, a Belgian biotech innovator,...
April 12, 2024 | News
D3 Bio Secures $62M in Series A+ Financing for Cancer Drug Development
D3 Bio, an emerging global biotechnology company that focuses on discovery, development, and registration of innovative cancer drugs announces its cl...
April 09, 2024 | News
Bridge Biotherapeutics Partners with University of Colorado for Cancer Research
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a...
March 27, 2024 | News
Bayer AG Partners with Thermo Fisher for Breakthrough in Cancer Treatment Diagnostics
Development of next-generation sequencing companion diagnostics (CDx) Goal is to help increase patient access to Bayer’s precision cancer therapie...
March 20, 2024 | News
FDA Grants Fast Track Designation to ImmVira's MVR-T3011 IT for Advanced Head and Neck Cancer
ImmVira's groundbreaking oncolytic virus therapy, MVR-T3011 IT intratumoral injection, has been awarded Fast Track designation by the U.S. Food and Drug Ad...
March 18, 2024 | News
BeiGene's TEVIMBRA Wins FDA Nod for Advanced Esophageal Cancer Post-Chemotherapy
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has app...
March 15, 2024 | News
TiumBio Advances TU2218 in Phase 2a Trial with Pembrolizumab for Three Cancer Types
TiumBio will pursue three indications for the TU2218 combination clinical trial with pembrolizumab TU2218 demonstrated a favorable safety and a synerget...
March 12, 2024 | News
Ono Pharmaceutical Forms Strategic Alliance with Harvard University for Drug Discovery
Ono Pharmaceutical announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University&nbs...
March 12, 2024 | News
Johnson & Johnson Completes $2 Billion Acquisition of Ambrx Biopharma, Bolstering Oncology Pipeline
Johnson & Johnson (NYSE: JNJ) announced it has successfully completed the acquisition of Ambrx Biopharma, Inc., a clinical-stage biopharmaceutica...
March 08, 2024 | News
Naveris Inc. Launches Pioneering NAVigate-HPV Registry to Enhance HPV Cancer Diagnostics
-Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the launch of the NAVigate-HPV Registry. This innov...
March 04, 2024 | News
BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced a strategic partnership with Camtech Health, a ...
February 22, 2024 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
